BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Research BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. (603392.SS) on Bullrun: market cap CNY 31.66B. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- Ticker603392.SS
- ExchangeSS
- CountryChina
- SectorHealthcare
- IndustryBiotechnology
- CurrencyCNY
- Market capCNY 31.66B
- Financial periodQ2 2026
- RevenueCNY 525.12M
- Net income-CNY 85.33M
- Free cash flowCNY 36.57M
- Gross margin58.0%
Valuation Snapshot
latest market cap is CNY 31.66B.
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-10-18 | CNY 31.66B | n/a | n/a | 0 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 0 CNY.
About BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells biological diagnostic tests and vaccines in China and internationally. The company offers in vitro diagnostics and automated laboratory instruments, including Wan600, Wan BC2800, WanTLA immunoassay and biochemistry analyzers; chemiluminescence and biochemistry tests, including novel diagnostic tests for detection of Hepatitis virus infections; P-85 Ab for nasopharyngeal cancer screening;
ETFs that hold BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.
US-listed ETFs
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. is held by 31 US-listed ETFs, going by the latest portfolios they filed with the SEC. The 8 most traded of them:
| ETF | Weight | Fee |
|---|---|---|
| iShares MSCI Emerging Markets ETF (EEM) | <0.01% | 0.72% |
| iShares Core MSCI Emerging Markets ETF (IEMG) | <0.01% | 0.09% |
| Vanguard Total International Stock Index Fund ETF Shares (VXUS) | <0.01% | 0.05% |
| Vanguard FTSE Emerging Markets Index Fund ETF Shares (VWO) | <0.01% | 0.06% |
| Vanguard Total World Stock Index Fund ETF Shares (VT) | <0.01% | 0.06% |
| Vanguard FTSE All-World ex-US Index Fund ETF Shares (VEU) | <0.01% | 0.04% |
| iShares Core MSCI Total International Stock ETF (IXUS) | <0.01% | 0.07% |
| Xtrackers Harvest CSI 300 China A-Shares ETF (ASHR) | 0.05% | 0.65% |
Portfolios as filed with the SEC on Form N-PORT, dated May to July 2026. Brokers in the EU generally do not offer US-listed ETFs to retail investors.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.'s market cap?
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.'s market capitalization is CNY 31.66B.
What does BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD. do?
Beijing Wantai Biological Pharmacy Enterprise Co., Ltd. research, develops, produces, and sells biological diagnostic tests and vaccines in China and internationally. The company offers in vitro diagnostics and automated laboratory instruments, including Wan600, Wan BC2800, WanTLA immunoassay and biochemistry analyzers; chemiluminescence and biochemistry tests, including novel diagnostic tests for detection of Hepatitis virus infections; P-85 Ab for nasopharyngeal cancer screening; and TB-IGRA for large population screening.